<< Back to Results
CALGB C80702 - A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer.
-
Clinical Trial Categories
- Contact
- The Rosenfeld Cancer Center at 215-481-2402
Location
- The Rosenfeld Cancer Center